Capital raised by top private RNA-based biopharma companies 2020

Total capital raised by leading private RNA-based biopharmaceutical companies worldwide in 2020 (in million U.S. dollars)

Capital raised by leading RNA-based private biopharma companies worldwide 2020

Last update:

Apr 1, 2022

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2020 to 31/12/2020

In 2020, Abogen Biosciences reported that it raised around 817.5 million U.S. dollars in capital funding, while Laronde reported around 490 million U.S. dollars raised. This statistic illustrates the total capital raised by leading private RNA-based biopharmaceutical companies worldwide in 2020, in million U.S. dollars.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Total capital raised by leading private RNA-based biopharmaceutical companies worldwide in 2020 (in million U.S. dollars)

Get in touch with us for additional information

��ƽ��